Modern AI technology is data-hungry. In many areas, data is scarce. For example, in our work in early oncology clinical trials, we only have data on about 20 patients, so we tend to use theory-based ...
StockStory.org on MSN16h
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
12h
Lake County Record-Bee on MSNNews BriefsSome are reworked bills that failed last year, including one that would require AI developers to evaluate and disclose whether their AI tools perform decisions that could affect someone’s employment, ...
8h
Pharmaceutical Technology on MSNAstraZeneca director says AI must be a “thought partner” in drug discoveryAstraZeneca’s senior director in oncology data science outlined how the company uses AI for drug discovery at a recent talk.
A directive from the National Institute of Standards and Technology eliminates mention of “AI safety” and “AI fairness.” ...
Patients expressed concern that overreliance on artificial intelligence (AI) could lead to clinicians losing their skills, ...
AI assistance was seen to speed screening and recruitment for clinical trials, potentially helping patients access novel therapies faster.
A new National Academies report recommends ways for the U.S. to reap the benefits of artificial intelligence in biotechnology ...
With AI Trust Score Manager, CISOs can operationalize controls, ensure compliance, and select the safest AI models for their needs.
The FDA has recalled several acne treatments from brands including La Roche-Posay and Walgreens due to benzene contamination.
Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results